|
1
|
Skaftnesmo KO, Prestegarden L, Micklem DR
and Lorens JB: MicroRNAs in tumorigenesis. Curr Pharm Biotechnol.
8:320–325. 2007. View Article : Google Scholar
|
|
2
|
Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu
Z and You Y: Hsa-mir-181a and hsa-mir-181b function as tumor
suppressors in human glioma cells. Brain Res. 1236:185–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
le Sage C, Nagel R, Egan DA, Schrier M,
Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafrè SA,
Farace MG and Agami R: Regulation of the p27Kip1 tumor
suppressor by miR-221 and miR-222 promotes cancer cell
proliferation. EMBO J. 26:3699–3708. 2007.
|
|
4
|
Zhang C, Kang C, You Y, Pu P, Yang W, Zhao
P, Wang G, Zhang A, Jia Z, Han L and Jiang H: Co-suppression of
miR-221/222 cluster suppresses human glioma cell growth by
targeting p27kip1 in vitro and in vivo.
Int J Oncol. 34:1653–1660. 2009.PubMed/NCBI
|
|
5
|
Zhang C-Z, Han L, Zhang A-L, Fu Y-C, Yue
X, Wang G-X, Jin Z-F, Pu P-Y, Zhang Q-Y and Kang C-S: MicroRNA-221
and microRNA-222 regulate gastric carcinoma cell proliferation and
radioresistance by targeting PTEN. BMC Cancer. 10:3672010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakano K and Vousden KH: PUMA, a
novel proapoptotic gene, is induced by p53. Mol Cell. 7:683–694.
2001. View Article : Google Scholar
|
|
7
|
Avila JL, Grundmann O, Burd R and Limesand
KH: Radiation-induced salivary gland dysfunction results from
p53-dependent apoptosis. Int J Radiat Oncol Biol Phys. 73:523–529.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Labi V and Villunger A: PUMA-mediated
tumor suppression: a tale of two stories. Cell Cycle. 9:4269–4275.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang C, Zhang J, Zhang A, Wang Y, Han L,
You Y, Pu P and Kang C: PUMA is a novel target of miR-221/222 in
human epithelial cancers. Int J Oncol. 37:1621–1626.
2010.PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tran N, O’Brien CJ, Clark J and Rose B:
Potential role of micro-RNAs in head and neck tumorigenesis. Head
Neck. 32:1099–1111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chiang WF, Hung PS, Liu SY, Yuan TC, Chang
KW, Chen YP, Liu YC and Lin SC: Increase of ZASC1 gene copy
number in recurrent oral carcinoma. Oral Dis. 17:53–59. 2011.
|
|
13
|
Childs G, Fazzari M, Kung G, Kawachi N,
Brandwein-Gensler M, McLemore M, Chen Q, Burk RD, Smith RV,
Prystowsky MB, Belbin TJ and Schlecht NF: Low-level expression of
microRNAs let-7d and miR-205 are prognostic markers
of head and neck squamous cell carcinoma. Am J Pathol. 174:736–745.
2009.PubMed/NCBI
|
|
14
|
Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY,
Wu KJ, Chiou SH, Lin SC and Chang KW: miR-31 ablates
expression of the HIF regulatory factor FIH to activate the HIF
pathway in head and neck carcinoma. Cancer Res. 70:1635–1644. 2010.
View Article : Google Scholar
|
|
15
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meister G and Tuschl T: Mechanisms of gene
silencing by double-stranded RNA. Nature. 431:343–349. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bagga S, Bracht J, Hunter S, Massirer K,
Holtz J, Eachus R and Pasquinelli AE: Regulation by let-7
and lin-4 miRNAs results in target mRNA degradation. Cell.
122:553–563. 2005.
|
|
18
|
Giraldez AJ, Mishima Y, Rihel J, Grocock
RJ, Van Dongen S, Inoue K, Enright AJ and Schier AF: Zebrafish
miR-430 promotes deadenylation and clearance of maternal mRNAs.
Science. 312:75–79. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu L, Fan J and Belasco JG: MicroRNAs
direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA.
103:4034–4039. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kozaki K, Imoto I, Mogi S, Omura K and
Inazawa J: Exploration of tumor-suppressive microRNAs silenced by
DNA hypermethylation in oral cancer. Cancer Res. 68:2094–2105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lo WL, Yu CC, Chiou GY, Chen YW, Huang PI,
Chien CS, Tseng LM, Chu PY, Lu KH, Chang KW, Kao SY and Chiou SH:
MicroRNA-200c attenuates tumour growth and metastasis of
presumptive head and neck squamous cell carcinoma stem cells. J
Pathol. 223:482–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lajer CB, Garnæs E, Friis-Hansen L,
Norrild B, Therkildsen MH, Glud M, Rossing M, Lajer H, Svane D,
Skotte L, Specht L, Buchwald C and Nielsen FC: The role of miRNAs
in human papilloma virus (HPV)-associated cancers: bridging between
HPV-related head and neck cancer and cervical cancer. Br J Cancer.
106:1526–1534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fornari F, Gramantieri L, Ferracin M,
Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM,
Bolondi L and Negrini M: MiR-221 controls CDKN1C/p57 and CDKN1B/p27
expression in human hepatocellular carcinoma. Oncogene.
27:5651–5661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Medina R, Zaidi SK, Liu CG, Stein JL, van
Wijnen AJ, Croce CM and Stein GS: MicroRNAs 221 and 222 bypass
quiescence and compromise cell survival. Cancer Res. 68:2773–2780.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gramantieri L, Fornari F, Ferracin M,
Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L and
Negrini M: MicroRNA-221 targets Bmf in hepatocellular carcinoma and
correlates with tumor multifocality. Clin Cancer Res. 15:5073–5081.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang C, Han L, Zhang A, Yang W, Zhou X,
Pu P, Du Y, Zeng H and Kang C: Global changes of mRNA expression
reveals an increased activity of the interferon-induced signal
transducer and activator of transcription (STAT) pathway by
repression of miR-221/222 in glioblastoma U251 cells. Int J Oncol.
36:1503–1512. 2010.PubMed/NCBI
|
|
27
|
Zhang CZ, Zhang JX, Zhang AL, Shi ZD, Han
L, Jia ZF, Yang WD, Wang GX, Jiang T, You YP, Pu PY, Cheng JQ and
Kang CS: MiR-221 and miR-222 target PUMA to induce cell survival in
glioblastoma. Mol Cancer. 9:2292010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen L, Willis SN, Wei A, Smith BJ,
Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM and Huang DC:
Differential targeting of prosurvival Bcl-2 proteins by their
BH3-only ligands allows complementary apoptotic function. Mol Cell.
17:393–403. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
John-Aryankalayil M, Palayoor ST, Cerna D,
Simone CB II, Falduto MT, Magnuson SR and Coleman CN: Fractionated
radiation therapy can induce a molecular profile for therapeutic
targeting. Radiat Res. 174:446–458. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Marignol L, Robson T, McCarthy HO,
Worthington J, Murray MM, Hollywood D, Lawler M and Hirst DG: The
tissue plasminogen activator gene promoter: a novel tool for
radiogenic gene therapy of the prostate? J Gene Med. 9:1032–1038.
2008. View
Article : Google Scholar : PubMed/NCBI
|
